Corporate Members

HomeAboutIndustry Resources ▶ Corporate Members
Corporate Membership

Corporate Member Program Header


The ATS 2020 Corporate Member Program runs from March 1, 2020 – February 28, 2021.

If you are interested in learning more about the program, please contact us for additional information.

Companies are also welcome to join the program throughout the year at a pro-rated membership rate.


ATS Corporate Membership is one of the best year-long ways that companies can become visible and engaged members of the ATS community.

When your company elects to become a Corporate Member of the ATS, it will be recognized as a supporter of the specialties of pulmonary, critical care and sleep by ATS Members in addition to receiving membership benefits. Some of those benefits can include:


  • Complimentary Affiliate Memberships for key staff, who participate in ATS Assemblies and get discounts on ATS International Conference registration
  • Complimentary subscriptions to ATS Journals and other member communications
  • Ability to list current clinical trial opportunities on the ATS Clinical Trial Resources page at no additional charge for members at the Supporter Level or higher.
  • A minimum number of acknowledgements in key ATS digital and print media at the ATS International Conference and throughout the year.
  • Corporate Member Banner Ad with buffered link to company homepage on the AJRCCM Journal website (Benefactor and Patron Levels only)
  • Invitations to 2 Corporate Member Events yearly for optimum engagement with ATS Officers, Key ATS Staff, and ATS Assembly and Committee members.
  • Complimentary Meeting Suite time at ATS 2020 (Benefactor and Patron Levels only)

...As well as many other benefits.


In addition, companies that join at the highest level will have a representative seated on the Corporate Advisory Board, which will meet regularly to discuss topics pertinent to medicine and industry. Companies that join at the lower levels still have an opportunity to participate. The ATS Executive Director will have the opportunity to appoint additional companies to ensure the Advisory Board is representative of the organizations interested in pulmonary, critical care and sleep.

Corporate Member companies will also have the opportunity to provide unbranded patient education resources to the 2020 Lung Disease Week at the ATS, hosted by the ATS Public Advisory Roundtable (ATS PAR). The ATS PAR is a society-wide initiative to recognize the many rare lung disorders for which ATS PAR member organizations provide support and guidance to patients and their families.


If you would like to see the full list of ATS 2020 Corporate Member benefits or a Highlight Binder from the 2019 Program, please contact Vlada O'Hara, Associate Director, Corporate Alliances at vohara@thoracic.org.